The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law BPC 157 Before and After: 1 Amazing Transformation